Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial.
- Resource Type
- Article
- Authors
- Motzer, Robert J.; Nosov, Dmitry; Eisen, Timothy; Bondarenko, Igor; Lesovoy, Vladimir; Lipatov, Oleg; Tomczak, Piotr; Lyulko, Oleksiy; Alyasova, Anna; Harza, Mihai; Kogan, Mikhail; Alekseev, Boris Y.; Sternberg, Cora N.; Szczylik, Cezary; Cella, David; Ivanescu, Cristina; Krivoshik, Andrew; Strahs, Andrew; Esteves, Brooke; Berkenblit, Anna
- Source
- Journal of Clinical Oncology; 10/20/2013, Vol. 31 Issue 30, p3791-3799, 10p
- Subject
- Language
- ISSN
- 0732183X